In ARS Pharmaceuticals, institutional investors hold a 30% stake, making them the most powerful shareholder group. Hedge funds, insiders, and private equity firms also have significant ownership. Analyzing these ownership groups can provide valuable insights for investors.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing